Market Intelligence Center  Jul 27  Comment 
Option-trade picking algorithms patented by MarketIntelligenceCenter.com found a trading opportunity with Bio Reference Labs (BRLI) that should provide a 4.94% return in just 53 days. Sell one Sep. '15 call at the $45.00 level for each 100 shares...
Forbes  Jul 23  Comment 
OPKO's acquisition of Bio-Reference Labs will transform it into a lab-testing market leader.
Market Intelligence Center  Jul 20  Comment 
Option-trade picking algorithms patented by MarketIntelligenceCenter.com found a trading opportunity with Bio Reference Labs (BRLI) that should provide a 6.89% return in just 123 days. Sell one Nov. '15 call at the $42.50 level for each 100 shares...
Market Intelligence Center  Jul 7  Comment 
After Monday’s trading in Bio Reference Labs (BRLI) the algorithms behind MarketIntelligenceCenter.com's Artifical Intelligence Center picked out a trade that offers a 7.98% or 21.41% (for comparison purposes only), while providing 9.43%...
Market Intelligence Center  Jul 1  Comment 
Bio Reference Labs (BRLI) presents a trading opportunity that offers a 3.90% return in just 51 days. A covered call on Bio Reference Labs at the $40.00 level expiring on Aug. '15 offers an assigned return rate of 3.90% or 27.88% annualized. This...
Benzinga  Jun 8  Comment 
Bio-Reference Laboratories Inc (NASDAQ: BRLI) shares climbed 5.70 percent to $41.88. The volume of Bio-Reference Laboratories shares traded was 258 percent higher than normal. Bio-Reference Laboratories reported Q2 earnings of $0.38 per share on...
TheStreet.com  Jun 8  Comment 
NEW YORK (TheStreet) -- Bio-Reference Labs shares are climbing 5% to $41.60 in early market trading on Monday despite missing analysts' earnings expectations after the company agreed to be acquired by Opko Health for $1.47...
TheStreet.com  Jun 5  Comment 
NEW YORK (TheStreet) -- Shares of Opko Health  were trading in the red, down 1.48% to $16.01 on heavy volume in midday trading Friday, adding to its losses from the prior session following its announcement that it will acquire Bio-Reference...

You may also be interested in articles related to Bio-Reference Laboratories (BRLI):

Bio-Reference Laboratory (BRLI) is the fourth largest full service laboratory in the United States and the largest independent regional laboratory in the Northeastern market. They offer a comprehensive list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases. They are primarily a clinical testing laboratory servicing physician offices with concentrations in the focused markets of esoteric testing, molecular diagnostics, anatomical pathology and correctional health care

BRLI currently processes nearly 4.6 million requisitions each year. A requisition form accompanies a patient specimen. It indicates the tests to be performed and the party to be invoiced for the tests. Clients include doctors, employers, clinics and governmental units. They have a network of over 80 patient service centers for collection of patient specimens.

In 2006, BRLI acquired GeneDx, a diagnostic genetic testing laboratory providing services to national and international customers. GeneDx specializes in testing for rare and complex genetic conditions through the use of DNA sequencing. In 2007 BRLI introduced the first commercially available genome-wide oligonucleotide microarray analysis testing useful for the diagnosis of,among other conditions, developmental disorders.

In 2008, BRLI became the first commercial laboratory in the world to offer NextGen

(high speed computerized sequencing) to analyze multi-gene conditions. These innovations have significantly grown GeneDx's business. The success and growth of GeneDx can be attributed to both the unique nature of our testing and the highly experienced clinicians and researchers who run the business. In addition to clinical testing operations, BRLI operates a clinical knowledge management service through the PSIMedica business unit. This system uses customer data from laboratory results, pharmaceutical data, claims data and other data sources to provide administrative and clinical decision support systems which enable our customers to provide quality and efficient healthcare to their populations.BRLI also operates a web-based connectivity portal solution for laboratories and physicians through their CareEvolve subsidiary. BRLI uses this portal ourselves to provide laboratory ordering and results to our physician customers. They also market and license this connectivity solution to other laboratories throughout the country.



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki